C12Y 109/03
Oxidoreductases acting on a heme group of donors: with oxygen as acceptor
Official title: with oxygen as acceptor (1.9.3)
C12Y109/03 (Oxidoreductases acting on a heme group of donors: with oxygen as acceptor) appears on 17 US grants and 41 published applications in this corpus.
Search patents in C12Y- Granted patents
- 17
- Published applications
- 41
- Assignees
- 25
- Inventors
- 68
- Latest grant
- 5 Mar 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 1 | 0 |
| 2014 | 0 | 2 |
| 2015 | 2 | 5 |
| 2016 | 0 | 2 |
| 2017 | 1 | 5 |
| 2018 | 1 | 4 |
| 2019 | 1 | 3 |
| 2020 | 2 | 2 |
| 2021 | 2 | 4 |
| 2022 | 1 | 3 |
| 2023 | 3 | 1 |
| 2024 | 1 | 3 |
| 2025 | 0 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compositions, devices and methods for the control in vitro of chemical microambient in cell cultures5 Mar 2024US 11,920,153 B2Alma Mater Studiorum - Università di Bologna
- Compositions and methods for mitochondrial genome editing10 Oct 2023US 11,779,657 B2City of Hope
- Methods of improving cell-based therapy15 Aug 2023US 11,723,929 B2The Regents of the University of California
- Importation of mitochondrial protein by an enhanced allotopic approach18 Jul 2023US 11,702,671 B2Institut National De La Sante Et De La Recherche Medicale (Inserm)
- Compositions and methods for treating leber's hereditary optic neuropathy with NADH dehydrogenase proteins14 Jun 2022US 11,357,869 B2Wuhan Neurophth Biotechnology Limited Company
- Compositions, devices and methods for the control in vitro of chemical microambient in cell cultures6 Aug 2026US 2026/0226408 A1Alma Mater Studiorum - Università di Bologna
- Applications of o2-insensitive formate dehydrogenase20 Nov 2025US 2025/0357519 A1University of Maryland, Baltimore
- Biosynthesis of oxygenated hydrocarbons6 Mar 2025US 2025/0075243 A1Ginkgo Bioworks, Inc.
- Compositions and methods for high efficiency genome editing24 Oct 2024US 2024/0350666 A1Children's Medical Center Corporation
- Compositions, devices and methods for the control in vitro of chemical microambient in cell cultures1 Aug 2024US 2024/0254436 A1Alma Mater Studiorum - Università di Bologna
Most cited
By later US patents
- Compositions and methods for the diagnosis and treatment of inflammatory disorders and fibrotic disease10US 8,486,909 B2Board of Regents of the University of Nebraska · 2013
- Transgenic plants including a transgene consisting of a hybrid nucleic acid sequence, comprising at least one unedited mitochondrial gene fragment from higher plants and process for producing them6US 5,914,447 ACentre National de la Recherche Scientifique (CNRS) · 1999
- Importation of mitochondrial protein by an enhanced allotopic approach3US 9,017,999 B2Institut National De La Sante Et De La Recherche Medicale (Inserm) · 2015
- Transgenic plants including a transgene consisting of a hybrid nucleic acid sequence, comprising at least one unedited mitochondrial gene fragment from higher plants and process for producing them2US 6,479,735 B1Centre National de la Recherche Scientifique (CNRS) · 2002
- Methods of diagnosing and treating Alzheimer's disease with S-equol1US 10,391,079 B2Ausio Pharmaceuticals, LLC · 2019